Freiburg TIPS Registry
Recruiting
Observational Study
Liver Cirrhosis
Portal Hypertension
Non-Cirrhotic Portal Hypertension
Budd Chiari Syndrome
Portal Vein Thrombosis
Portal Systemic Shunt
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 100
- Sex
- Any
- Study type
- Observational
- Participants needed
- 2,000 (estimated)
- Sponsor
- University Hospital Freiburg · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Patients with clinically significant portal hypertension allocated to implantation of a transjugular intrahepatic portosystemic shunt (TIPS) at the Department of Medicine II of the University Medical Center Freiburg, Germany will be offered to participate in this prospective observational trial.
Clinical and laboratory as well as outcome parameters will be assessed before and within the first 12 …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients allocated to TIPS implantation due to clinically significant cirrhotic and non-cirrhotic portal hypertension
Exclusion Criteria:
* Withdrawal of written informed consent
Contacts